Ignite Creation Date:
2024-05-06 @ 1:06 PM
Last Modification Date:
2024-10-26 @ 1:09 PM
Study NCT ID:
NCT03937830
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2019-05-03
Brief Title:
Combined Treatment of Durvalumab Bevacizumab Tremelimumab and Transarterial Chemoembolization TACE in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma
Sponsor:
Organization:
National Institutes of Health Clinical Center CC